Woman lying in bed grabbing her head in pain due to a headache

How to Treat and Prevent Medication Overuse Headaches

Woman lying in bed grabbing her head in pain due to a headache

Over 1.5% of the population experiences Medication Overuse Headaches (MOH). This type is the most common migraine-like headache. People with MOH experience pain over 15 days each month. MOH ranges higher in women (2.6%) and people over 50 years of age (nearly 5%).

Medication Overuse Headaches excessive use of analgesics and other migraine abortive drugs are believed to contribute to transformation of episodic migraine into chronic migraine. This transformation results in more frequent and more severe headaches. Older terminology includes analgesic rebound headache, drug-induced headache, medication-misuse headache, and withdrawal headache.

Like what you’re learning?  Download a brochure for our online, postgraduate Orofacial Pain and Oral Medicine degree program.

 

Download a Brochure

 

Treatment & Prevention

There are two goals in the treatment of Medication Overuse Headaches. The first is to reduce, eliminate, or decrease the severity of headaches.

The second and most viable form of treatment is the discontinuation of overused acute medications. The treatment can involve termination of persistent headaches by use of preventive medications, instruction in appropriate use of abortives, or behavioral therapy to change drug use and habits. This treatment can be as inpatient or outpatient depending on the number and type of overused substance and whether there is adequate family support structure and patient motivation.

Related Reading: New Treatments for Chronic Migraines are on the Horizon

 

Medications & MOH

Overused Medications Associated with MOH

  • Analgesics: overused in 34.7% of MOH cases
  • Combination of migraine drugs: overused in 27.8%
  • Triptans: overused in 22.2%
  • Opioids: overused in 12.8%
  • Ergotamine tartrate drugs: overused in 2.7%

There are additional drugs that are associated with MOH. The following medications are more uncommon, but still related to the diagnosis.

Additional Drugs More/Are Associated with MOH

  • NOAs (e.g. acetaminophen)
  • Fiorinal and Fioricet
  • Salicylates

In addition to causative drugs, there are multiple drugs that are proven to not cause MOH. The following drugs are listed below.

Drugs Less/Not Associated with MOH Induction

Related Reading: Commonly Used Medications For Temporomandibular Disorders

Finally, there are specific drug use guidelines that are recommended to avoid MOH prior to experiencing pain. These guidelines can also provide insights into other causes of MOH.

Drug Use Guideline to Prevent MOH by Dosage

  • Simple Analgesics taken maximum of 15 days per month
  • Opiate (e.g., codeine) taken maximum of 10 days per month
  • Triptans taken maximum of 10 days per month

Medication Half-Life

The following time periods are each medication’s half-life. A shorter time will be most likely to be taken more often. They are recommended to be avoided.

  • Acetaminophen taken 2 to 4 hours
  • Aspirin (salicylate) taken 6 hours
  • Ibuprofen taken 2 hours
  • Naproxen taken 12 to 17 hours
  • Nabumetone taken 24 hours
  • Codeine taken 2.5 to 4 hours
  • Hydrocodone taken 24 hours
  • Sumatriptan (Imitrex) taken 2.5 hours
  • Rizatriptan (Maxalt) taken 2 to 3 hours
  • Naratriptan (Amerge) taken 6 hours
  • Eletriptan (Relpax) taken 13 hours

 

Postgraduate Orofacial Pain and Oral Medicine Master’s Degree

Learn more about treating your patients’ pain by enrolling in Herman Ostrow School of USC’s online, competency-based certificate or master’s program in Orofacial Pain and Oral Medicine.

 

Get More Information

 

The information and resources contained on this website are for informational purposes only and are not intended to assess, diagnose, or treat any medical and/or mental health disease or condition. The use of this website does not imply nor establish any type of provider-client relationship. Furthermore, the information obtained from this site should not be considered a substitute for a thorough medical and/or mental health evaluation by an appropriately credentialed and licensed professional. Commercial supporters are not involved in the content development or editorial process.

About Dr. Glenn Clark

Glenn Clark, DDS, MS is an expert on sleep apnea, orofacial pain and oral medicine, and Temporomandibular Joint Disorder (TMJ). Dr. Clark serves as the Director for the Advanced Program in Orofacial Pain and Oral Medicine at the Herman Ostrow School of Dentistry of USC.